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Interactions between disease dynamics and vaccinating behavior have been explored in many
coupled behavior-disease models. Cognitive effects such as risk perception, framing, and subjective
probabilities of adverse events can be important determinants of the vaccinating behaviour, and
represent departures from the pure “rational” decision model that are often described as “bounded
rationality”. However, the impact of such cognitive effects in the context of paediatric infectious
disease vaccines has received relatively little attention. Here, we develop a disease-behavior
model that accounts for bounded rationality through prospect theory. We analyze the model and
compare its predictions to a reduced model that lacks bounded rationality. We find that, in general,
introducing bounded rationality increases the dynamical richness of the model and makes it harder
to eliminate a paediatric infectious disease. In contrast, in other cases, a low cost, highly efficacious
vaccine can be refused, even when the rational decision model predicts acceptance. Injunctive social
norms can prevent vaccine refusal, if vaccine acceptance is sufficiently high in the beginning of the
vaccination campaign. Cognitive processes can have major impacts on the predictions of behaviourdisease models, and further study of such processes in the context of vaccination is thus warranted.

Processing imperfect information in limited time with bounded cognition affects individual
decision-making. Risk aversion and ambiguity aversion render the rational decision model of classical utility theory more of a prescriptive model than a descriptive model1. Cognitive psychologists and
behavioral economists have demonstrated such ramifications through numerous experiments, e.g.1,2,
corroborated by the St. Petersburg, Allais, and Ellsburg paradoxes3. In the 1970s and 80s, H.A. Simon
introduced the concept of bounded rationality to explain deviations from the rational decision model4–6.
In the meantime, Kahneman and Tversky7 developed Prospect Theory (PT) through experimental psychology to explain and describe how individuals make decisions. According to PT, individuals measure
their utility of each possible outcome based on how it is framed and on the perception/weight of the
probabilities of its occurrence. Prospect theory has received significant attention in the decision-making
community1,2,8, behavioral economics9–11, health12,13 and many other fields14–17.
Prospect theory attempts to explain how multitudinous everyday decisions are influenced by risk (mis)
perception, range effect, loss aversion, diminishing sensitivity and framing effect. The decision whether
or not to vaccinate should also be subject to these effects. While vaccination is a very efficient control
measure for many paediatric infectious diseases18–20, some parents do not vaccinate their children. That
appears to be due to the underestimation of disease risks and/or overestimation of vaccine risks, and
vaccine-generated herd immunity21–27. According to the Health Belief Model (HBM), parents decide
about childhood vaccination according to two types of variables: personal and social22,28–31. Personal
variables include parental perceived risk of infection in terms of susceptibility and severity, perceived
risk of vaccination, vaccine efficacy, vaccine cost, and its accessibility. For instance, low perceived vaccine
efficacy can be detrimental to vaccination campaigns32. Social variables include injunctive social norms
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(group pressure) experienced through peers and health care providers. For instance, injunctive social
norms affect vaccine uptake in different ways that depend on the initial size of the vaccinator group33.
Other research has pointed to the ubiquitous role of social learning in vaccine decision-making, where
individuals rely upon information provided by their broad social environment—peers, health care providers, and the media—to make their decisions34.
Many mathematical models of the interaction between vaccinating behavior and disease incidence
predict that vaccination is not an effective method of disease elimination, because herd immunity makes
vaccine refusal attractive to parents25,32,33,35–42. Refusal can emerge with or without a rational decision
model. For example, behavioral economic models that incorporate bounded rationality can replicate
the low acceptance rate of influenza vaccination in the United States43. Another behavioral economy
framework found that subjective risks, efficacy, and cost of vaccination can also explain low acceptance
rates44. The final size of epidemics and vaccine uptake were shown to be sensitive to strategic decisions
towards vaccination in the case of imperfect information about disease risk in the presence of discount
rate bias45, and when disease risk perception is based on partial recall of historical prevalence46. A similar
conclusion is reached in the case where decisions are made to reduce contact rates, when disease risk
perception depends on recalling the number of symptomatic cases over a certain past period of time47.
Moreover, the clustering of opinions on networks itself (i.e. without feedback from disease dynamics) can
also affect the herd immunity threshold in ways that make it harder to eliminate infection48. In contrast,
other approaches observe that pediatric vaccine coverage is often higher than predicted by the conventional free-rider framework, and show that adding injunctive social norms or public health information
to models can reconcile the models to this observation33,41. These and other “behavior-disease” models
have begun moving away from the rational decision model in various ways25,32,33,35–42,49.
In this paper, we incorporate prospect theory into a behavior-disease model to investigate the
dynamical behavior of parental acceptance of paediatric infectious disease vaccines under the bounded
rationality paradigm. To our knowledge, this is the first paper that incorporates prospect theory into
a behaviour-disease modelling framework that also includes parameters governing costs, effecacy and
social norms. It thus allows us to capture how changes in individual cognitive processes described by
prospect theory can affect population-level vaccine coverage and disease dynamics. Also, in contrast to
how injunctive social norms are modelled in33, we allow injunctive social norms (group pressure) to
differ between vaccinator and non-vaccinator groups, since in reality those two groups might impose
pressures of different magnitudes. We study the dynamical behavior of the model and identify different
regions with different long-term states, comparing them to outcomes in a special case of the model that
lacks bounded rationality (i.e. a model that is closer to a rational decision model). We show how changes
in the perceived risks of vaccine and disease can translate into different equilibria. Vaccine efficacy32 and
cost of vaccination are also shown to affect the equilibrium at the same levels of risk perceptions. After
analyzing the model to identify its dynamical regimes, we will then use some published parameter values
to investigate the effect of the new parameters on the dynamical behavior of vaccine uptake/acceptance.

Methods

Modeling Decision-Making via Prospect Theory. A decision made according to prospect theory
starts by editing the prospects via combining, segregating, canceling and simplifying the prospects14. A
prospect Φ  =  (z1,p1; z2,p2; …; zk,pk), given after the editing phase, is defined by possible outcomes zi
(z i ∈ ) and their corresponding probabilities pi (0 <  pi <  1). A prospect Φ  =  (z1,p1; z2,p2; …; zk,pk) has
a utility given by

π (Φ) =

k

∑ω (pi ) u (z i)
i= 1

c.f.50. (Specifications of the two functions ω and u are given below.) However, in the case of a prospect of
only two possible outcomes with the same sign, an adjustment is needed; that is, if Φ  =  (z1,p1; z2,p2) with
p1 +  p2 =  1 and either 0 <  z1 <  z2 or z2 <  z1 <  0, then the utility would be given by π(Φ ) =  u(z1) +  ω(p2)
[u(z2) −  u(z1)].
The decision-maker prefers a prospect Φ 1 to another prospect Φ 2 if π(Φ 1) >  π(Φ 2) and is indifferent if
π(Φ 1) =  π(Φ 2). Prospect theory, however, violates the stochastic dominance axiom, because prospect Φ 1
may be preferred to Φ 2, even though outputs of prospect Φ 2 stochastically dominate prospect Φ 1 c.f.50.
That violation was fixed later in cumulative prospect theory (CPT)2, but we use here the classical prospect
theory as a tractable approximation to CPT (see Appendix III).
The subjective utility function is defined by u(x) =  uG(x)I+(x) +  uL(x)(1 −  I+(x)) where I+(x) is the
indicator function that equals one if x is positive and zero otherwise, uG(x) =  xα, and uL(x) =  − λ (− x)α
such that 1 >  α >  0 and λ  >  1 is the loss aversion index2,14. The concavity of uG and convexity of uL reflect
the different behaviors, either averting or seeking risk, when the object is framed in terms of gain or
loss, respectively, with respect to some reference point (Fig. 1(a)). It also reflects the bias in sensitivity
due to framing, to lose some amount rather than to gain the same amount, as a result of the inclusion
of the loss aversion index λ .
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Figure 1. Utility function and probability perception/weight. (a) The gain and loss utilities of the
objective/actual value measured with respect to a reference point. The plot corresponds to the parameters
α =  .5 and λ =  2.5. (b) The perception/weighting function ω of actual probabilities at parameter value η =  .5,
see equation (1).

The weighing of the likelihood of an event happens in a two-stage process51. First the decision maker
estimates the probability of the event (p), and second he/she assigns a weight to it (ω(p)). The weight function should reflect the compression effect for the objective or true probabilities. That compression results
in an overestimation of low probabilities and underestimation of high probabilities. The weight function
ω has a number of other properties: sub-certainty or ω(p) +  ω(1 −  p) <  1, and the pseudo-certainty feature of human cognition: people value a decrease in probability from 0.1 to 0 more than they value a
decrease from 0.2 to 0.1, for example. An example of the weight function ω of a probability p is depicted
in Fig. 1(b), and the function is given by

ω (p) =

pη
1

(pη + (1 − p)η ) η

(1)

where 0 <  η <  1 2,52. The case η ≃ 0 corresponds to complete denial of the event unless it is certain. We
will call the parameters α, λ, and η the cognitive parameters.

Behavior-disease model. We build a behavior-disease model that couples disease transmission

dynamics to vaccinating behavior dynamics (see e.g.25,35), in which susceptible babies are born at a rate
of μ (1 −  xe) where μ is the birth/death rate, x is the proportion of vaccinators (and rate of vaccination)
and e is the vaccine efficacy. The model is intended to apply to paediatric infectious diseases such as
measles, pertussis, and chicken pox. The model is given by

dS
= μ (1 − xe) − β S I − μ S
dt
dI
= β S I − (μ + γ ) I
dt
dx
= κ x (1 − x ) P (π V N (I, x ) ) − P (π N V (I, x ) )
dt

(

)



















(2)

where S and I are the proportions of susceptible and infected individuals in the population, β is the
disease transmission rate, and γ is the recovery rate. (The differential equation for the proportion of
recovered individuals R is redundant and so does not appear.) A parent is either a vaccinator V or
non-vaccinator N. In the behavior equation of the model, parents sample one another at a rate of κ and
compare their payoff to the sampled parent’s payoff; then they pick up the other parent’s strategy with
a probability given by a function in the difference of the payoffs. A non-vaccinator parent perceives a
difference between vaccination and non-vaccination strategies of πV|N =  πN(V) −  πN(N) and a vaccinator
parent perceives a difference between non-vaccination and vaccination strategies of πN|V =  πV(N) −  πV(V)
(see below for their definitions). Both are dependent on the disease prevalence I and the rate of vaccination x.
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The probability function P is defined by P (z ) =
for some constant c >  0 (see32) so that
1 + exp (−c z )
the larger the value of z is, the closer the value of the function P(z) is to one. P(πV|N) is the probability
that a parent switches from non-vaccinator to vaccinator strategy and P(πN|V) is the probability that a
parent switches from vaccinator to non-vaccinator strategy.
Within each of the two groups V and N, it is expected that due to the omission bias53 (harms of
commission exceeds the harms of omission) parents might show different loss aversion parameters λ
when considering risk of vaccination versus risk of non-vaccination. Let the subscripts c and o be used
to emphasize the commission and omission of actions. While the relationship between values of the
loss aversion parameters λc and λo is unclear in the case of vaccination decision-making, it is valid to
postulate that the loss aversion parameter of commission is greater than that of omission. That is, if two
prospects of omission and commission are of the same outcomes and probabilities then the utility of
the prospect due to commission would be greater than of the prospect due to omission if and only if
λc >  λo. While the values of the loss parameters will not be restricted to that inequality, as it seems that
the omission bias in the underlying problem is complicated by the values of the prospect.
We assume that all babies are born healthy and their parents’ goal is to maintain the healthy status
of their children. When an individual encounters some information about vaccination or disease, he/she
reflects upon it from his/her own perspective (or current strategy). Then, the utilities will be given by

π N (N ) =

π N (V ) =

j=0

3

3

j=0

j=0

∑ω N (q j ) u N,c (V j − B − m) + ∑ω N ( (1 − e) (I + ε) p j ) u N,o (J j − B − m)
π V (N ) =

π V (V ) =

3

∑ω N ( (I + ε) p j ) u N,o (J j − B)

(3)

(4)

3

∑ωV ( (I + ε) p j ) uV ,o (J j − B)
j=0

3

3

j=0

j=0

∑ωV (q j ) uV ,c (V j − B − m) + ∑ωV ( (1 − e) (I + ε) p j ) uV ,o (J j − B − m)

(5)

(6 )

Here, B =  1 is the utility of the healthy status (the reference point); J0, J1, J2, J3 are the utilities of mild,
moderate, morbid, and death due to disease that occur with probabilities p0, p1, p2, p3 to an infected child
such that 1 =  B ≥  J0 >  J1 >  J2 >  J3 ≥  0. The quantities V0, V1, V2, V3 are the utilities of no-side-effect, mild,
morbid, and death due to adverse reaction to vaccination that occur with probabilities q0, q1, q2, q3 to a
vaccinated child such that 1 =  B ≥  V0 >  V1 >  V2 >  V3 ≥  0. The quantity m is the utility (normalized and
given in utils) of cost and effort to access vaccination. (We assume that all of the utilities are in units
of ‘utils’.) The parental perception of the probability of getting infected is proportional to the current
prevalence I offset by a small probability 0 <  ε < <  1 making a total of I +  ε to account for that at zero
prevalence there might be a very faint fear of infection due to immigration. (The quantity ε is also mathematically important in the analysis of the model.) The quantity (1 −  e)(I +  ε)pj is the probability that a
vaccinated child gets a disease reaction of type Jj after getting infected by internal or external sources of
infection as the vaccine fails to work. The vaccine efficacy will always affect the disease incidence. It will,
however, have effect on vaccination behavior in the bounded rational case only (see results).
Social norms and peer group pressure are important factors in immunization uptake33,54. Therefore we
postulate the following: each group adopting a strategy Θ imposes a social group pressure given by δΘ
on the population. Thus an individual adopting strategy Θ experiences an average social pressure given
by pΘ δΘ, where pΘ is the proportion of strategy Θ ′ s adopters/supporters. The group pressures δV and δN
are normalized to be between 0 and 1 and are given in ‘utils’. Hence,

π V N (I, x ) = (π N (V ) + δ V x ) − (π N (N ) + δ N (1 − x ))
= π N (V ) − π N (N ) + (δ V + δ N ) x − δ N

( 7)

π N V (I, x ) = (π V (N ) + δ N (1 − x )) − (π V (V ) + δ V x )
= π V (N ) − π V (V ) + δ N − (δ V + δ N ) x

(8 )

where πN(V), πN(N), πV(N), and πV(V) are given by equations (3)-(6). This means that the utility of the
vaccination prospect πΘ(V) is augmented by the amount of the vaccinators’ group pressure δV x and the
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utility of the non-vaccination prospect πΘ(N) is augmented by the non-vaccinators’ group pressure δN
(1 −  x).

Results

The “rational decision model” is recovered as a special case of the full cognitive behavior-disease model,
in which the cognitive parameters, αΘ, ηΘ, and λ Θ, for Θ  =  V,N and  = c , o are set equal to one (see
Table 1 in Appendix I). However, we point out that even the “rational decision model” is not a pure
rational decision model since it allows for processes of social learning and social norms. Therefore our
use of the term is relative. The rational decision model is identical to the model in33 in case of perfect
vaccine efficacy and equal group pressure. When the parameters αΘ, ηΘ, and λ Θ, are not equal to one,
we refer to the model as a “bounded-rational decision model”.
In our analysis, we explore what happens as the parameters αΘ, ηΘ, and λ Θ, move away from the
rational decision model to the bounded rational decision model. This results in a plethora of dynamical
behaviors of vaccine acceptance, giving rise to new model equilibria relative to the rational case33. We
explore how dynamics depend on vaccine efficacy, vaccine cost, and social norms.
The model (equation (2)) has six fixed points. Three fixed points are disease-free equilibria:
 1 = (S, I, x ) = (1 − e, 0 , 1) (pure vaccinator, disease-free),  2 = (1 , 0 , 0) (non-vaccinator,
disease-free), and  3 ≡ (1 − e x 3, 0 , x 3) (partial vaccinator, disease-free; x3 is a function of various
model parameters, and its full expression appears in Appendix II).
The remaining three fixed points are disease-endemic equilibria that depend on the quantity
β (1 − xe )
 0 (x ) : = μ + γ .  0 (x ) is an effective reproduction number in the presence of a partially immune
population. Hence, the basic reproduction number R0 is given by R 0: =  0 (0). The three endemic equiR0 (1) − 1
R0 (0) − 1
μ
1
libria are: E 4 = 1 , μ
, 1 (pure vaccinator, disease-endemic), E 5 =
,
,0

(

R0

μ+γ

R0

)

(

R (x ) − 1

)

(

R0

μ+γ

R0

)

0 6
(no vaccinator, disease-endemic), and E 6 = 1 , μ
, x 6 (partial vaccinator, disease-endemic;
R0 μ + γ
R0
see Appendix II for a definition of x6).
Details about the existence of the equilibrium points and their stability conditions appear in Appendix
II, but we summarize the findings in this and the following paragraphs. The dependence of the equilibria
on model parameters is generally intuitive. The pure vaccinator, disease-free equilibrium ( 1) is stable if
the disease is not highly contagious and the vaccine is not very scary compared to the strength of the
vaccinator group pressure (the average vaccine risk with immigration (see Appendix II) is less than the
vaccinator group pressure). In contrast, the non-vaccinator, disease-free equilibrium ( 2) is stable when
the disease cannot sustain its spread and non-vaccinator pressure is considerable. The partial vaccinator,
disease-free equilibrium ( 3) is not stable whenever it exists, because in the absence of disease, social
norms will always move vaccine coverage up or down from an intermediate vaccine coverage, hence the
steady state is unstable.
The pure vaccinator, disease-endemic equilibrium ( 4) is stable if and only if vaccinator pressure is
sufficiently large and the vaccine efficacy is not too large (otherwise, the disease would be eliminated).
That is, under the appropriate vaccinator pressure, the vaccine can be used to mitigate or completely
eliminate a disease depending on its efficacy. The non-vaccinator, disease-endemic equilibrium ( 5) is
stable if and only if the non-vaccinator pressure is sufficiently large. Finally, the partial vaccinator,
disease-endemic equilibrium ( 6) is stable under some highly specific technical conditions (see Appendix
II).
The vaccine should be supported by a vaccinator social pressure larger than the average vaccine risk
with immigration (see Appendix II). This was also found by Oraby et al.33, but for the rational decision
model and a completely efficacious vaccine. However, in the current model, the average vaccine risk
depends on the cognition of the parents and in many cases, the (perceived) vaccine risk is increasing as the cognitive parameters move away from the rational decision model (Appendix IV, Figures
A1-A6). Additionally, in the current model, incorporating vaccine efficacy as a parameter resulted in
the emergence of a new equilibrium point (pure vaccinator, disease-endemic)33. This new equilibrium
can be maintained if the average vaccine risk at the disease-endemic prevalence is less than the social
pressure of vaccinators. Again, the vaccine risk depends on the cognitive parameters and in many cases
it increases as the cognitive parameters move away from the rational decision model (see Appendix IV
Figures A1-A6). If the vaccine is sufficiently efficacious, full vaccine coverage can eliminate the infection.

Simulation results.

Numerical simulations presented via parameter planes that show the various
dynamical regimes of the model provide a clearer picture of the impact of introducing bounded cognitive
processes. For baseline parameter values of the numerical simulation, we use a basic reproduction number R0 =  17, a birth/death rate of μ =  1/50 year−1, and a recovery rate of γ  =  365/22 year−1 from published
estimates of pertussis25. According to the Centers for Disease Control and Prevention, approximately 1
in 8 of children infected by pertussis suffers from pneumonia, 1 in 20 suffers from encephalitis, and 1 in
1,500 dies55. We assume that only the severest disease outcomes was reported (so the events were mutually exclusive); then we take p1 =  1/8, p2 =  1/20, p3 =  1/1500 and p0 =  1 −  (p1 +  p2 +  p3). The diphtheria,
tetanus, and pertussis acellular vaccine (DTaP) can cause side effects from mild reactions to acute
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encephalopathy. No death has been proven from DTaP vaccination so far. It can, however, cause continuous crying followed by full recovery for 1 in 1,000 vaccinated children, convulsions or shock followed
by full recovery for 1 in 14,000, and acute encephalopathy for 0-10.5 in 1,000,000 55. We assume that
q1 =  1/1000, q2 =  1/14000, q3 =  10.5/1000000 (the worst case) and q0 =  1 −  (q1 +  q2 +  q3). Since there is no
documented objective measure of the quality of life of repercussions for the disease and vaccination, we
assume that V0 =  .99, V1 =  .7, V2 =  .3, and V3 =  .1; whereas J0 =  .9, J1 =  .5, J2 =  .1, and J3 =  0. We choose
a negligible ε of value 10−20. These parameter values are summarized in Appendix I, Table 1. The cognitive parameters, αΘ, ηΘ, and λ Θ, for Θ  =  V,N and  = c , o, see Table 1 in Appendix I, are assigned
different sets of values to showcase the different dynamical behaviors of the vaccination rates and incidence.
Under the rational decision model, at baseline parameter values, there are three parameter regimes
in the m −  e parameter value (Fig. 2(a)), meaning that three different types of dynamics can emerge
depending on parameter values. A sufficiently costly vaccine (large m, as might apply at times of war,
for example, when the vaccine cost and accessibility are large) will always result in zero vaccine coverage. However, if the vaccine is less expensive, then two regions of bistability (regions II and III) are
encountered, where the outcome can either be no vaccination or full vaccination in each one of them,
depending on the initial conditions (Fig. 2(a)). The bistability emerges because social norms can drive
vaccine coverage up or down, depending on whether vaccinators or non vaccinators are initially more
numerous. Moreover, in the bistability region II, if vaccine efficacy is sufficiently small, then the disease
can become endemic despite full vaccination, whereas if vaccine efficacy is sufficiently large (region III),
then the disease can be eradicated in the presence of full vaccination (Fig. 2(a)). The cut-off point (M) in
vaccine cost m that separates the region of no vaccination and the region of bistability (full or no vaccination) depends on the amount of vaccinator pressure δV (Fig. 2(b)). At sufficiently large vaccine efficacy
and sufficiently large initial acceptance of vaccine, the effect of larger costs can be offset by sufficiently
large group pressure, resulting in disease eradication (Fig. 2(b)).
When the cognitive parameters αΘ, ηΘ, and λ Θ, are changed such that the system moves from the
rational decision model to the bounded rationality model (as depicted in Fig. 3; see explanation below),
the model predictions change dramatically. This is visible upon a casual inspection of the parameter
regimes for the bounded rational model case (Fig. 2(c)) versus the rational decision model case for a
range of values of the vaccine cost m and efficacy e (Fig. 2(a)); we observe that the number of different
possible dynamical behaviours has increased, and the boundaries between the different regions have
become nonlinear (see also Figs. 2(d) and 4(e) for the bounded rational model). Hence, a wider range
of population behaviours are possible, when individuals are subjected to bounded cognitive processes.
The pure vaccinator, disease-free equilibrium is replaced by a region of limit cycles (region V in Fig. 2(c)),
where vaccine coverage and the proportion of vaccinators in the population oscillate over time
(Fig. 2(c) versus 2 (a), see also Fig. 2(d,e)). A stable region of partial vaccination (region III in Fig. 2(c)),
which shares a bistability region (region II) with null vaccination, emerges as well. The region of full
vaccination and endemic disease (region IV) shrinks. For another choice of cognitive parameters, the
shape of the pure vaccinator, disease endemic stability region (region II in Fig. 4(e)) changes shape at a
different vaccine cost. The vaccine may be fully accepted within a range of vaccine efficacy similar to that
of DTaP vaccine (from 80% to 90%56) but at low cost of vaccination (see Fig. 2 (c) and 4(e)). The disease,
however, cannot be eradicated because of insufficient vaccine efficacy. Introducing bounded cognitive
processes in particular has, therefore, removed the possibility of disease eradication under voluntary
vaccination, at least for the baseline parameter values (Appendix I Table 1).
Next, the relationship between the rational model and the bounded rational model is further explored,
by determining what happens when the cognitive parameters αΘ, ηΘ, and λ Θ, are changed gradually,
starting from values corresponding to the rational model and moving to values corresponding to the
bounded rational model. We plotted a series of parameter planes where all the cognitive parameters are
fixed at unity, except for those which are being varied along the axes of the parameter planes across a
range including the unitary values corresponding to the rational decision model (Fig. 3). In particular,
stability regions of the αV–αN, λV,c–λN,c, and ηV–ηN planes are explored at vaccine cost m =  0 and vaccine
efficacy e =  .95 (Fig. 3). In all of the figures, the non-vaccinator, disease-endemic equilibrium ( 5) is
always stable, whatever was the group pressure, in contrast to the rational decision model in33 where it
is stable in a limited region. The pure vaccinator, disease free equilibrium ( 1) appears as another stable
equilibrium in a region containing the rational decision model, which is represented by the pair (1,1) in
the parameter plane. That region depends on the amount of group pressure (Appendix IV for Figures
A1, A2, and A3). In other words, given a fixed group pressure, shifting away enough from the pair (1,1)
(the rational decision model) and into the bounded rational model, makes it impossible to achieve any
vaccine acceptance. The size of that region is also dependent on the vaccine cost (see also Appendix IV
for Figures A1, A2, and A3 for vaccine cost m =  0,.01, and .02). Similar conclusions follow when efficacy
e =  .9 but then the pure vaccinator, disease endemic equilibrium ( 4) appears in lieu of  1 and so the
disease cannot be eradicated at all (see Appendix IV for Figures A4, A5, and A6 when m =  0,.01, and
.02). In general, introducing bounded rationality into the model makes it harder to eradicate the infection (compare the blue regions of endemic disease, which occur away from the rational (1,1) case, to the
red regions containing (1,1) in Figures A1, A2, A4, A5), although there are exceptions (Figures A3 and
Scientific Reports | 5:10724 | DOI: 10.1038/srep10724
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Figure 2. Various dynamical behaviors of vaccine uptake emerge at different values of vaccine cost and
efficacy in the rational decision model. (a,b) and the bounded-rationality model (c,d). e-m plane at
δV =  0.02 of the rational decision model (a) and the bounded-rationality case (c,d) at cognitive parameters
αV =  0.8271, αN =  0.9480, λV,o =  9.4515, λV,c =  1.7600, λN,o =  1.9011, λN,c =  1.7438, ηV =  0.2827, ηN =  0.5114. In
(a) there are two bistability regions where the equilibrium points  1 and  5 are stable in region III, and the
equilibrium points  4 and  5 are stable in region II. Besides, equilibrium point  5 is stable in region I and in
an extremely narrow stripe between the two bistability regions II and III (bounded by e =  0.941159 and
e =  0.941176). M =  .00975 is the cutoff vaccine cost in case δV =  0.02 in (a) (see also panel (b)). (b) A
R0 (1) − 1
contour plot for values of M μ
calculated at each pair of (e,m) in the rational decision model.

(

μ+γ

R0

)

The full vaccination equilibrium point  4 is stable in the regions where δV is larger than the value of
R0 (1) − 1
μ
and equation (8) in Appendix II is valid, that is e <  0.941159. With deviation from the
M

(

μ+γ

R0

)

rational decision model, a different e—m plane emerges in (c). There, a bistability region (II) of the
equilibrium points  5 and  6 transpires as well as other regions of stability for  4 in IV,  5 in I, and  6 in III.
Limit cycles appear in region V. (d) e—δV plane of stability, at m =  0, in which the equilibrium point  4 is
stable in region I and  6 in region II while limit cycles appear in region III. In both (c) and (d), the line
between the regions where  6 is stable and the limit cycles is a supercritical Hopf bifurcation line whereas
the rest of the lines are stability changing bifurcation lines. Limit cycles of vaccine coverage rate (e) and
incidence (f) at δV =  0.02, m =  0, and e =  0.99. The rest of the parameters are κ =  1.69,c =  1.46,δN =  0.02 in all
of the subpanels.
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Figure 3. Deviations from the rational decision model influence the vaccine uptake levels. (a) αV—αN
plane, (b) λV,c—λN,c plane with λV,o =  λV,c and λN,o =  λN,c, and (c) ηV—ηN plane at m =  0 and δV =  0.02. The
equilibrium points  1 (pure vaccinator, disease-free) and  5 (no vaccinator, disease-endemic) are stable in
the red region which includes the point (1,1)—corresponding to the rational decision model, given the
values of the rest of the cognitive parameters equal to one–whereas in the blue region the only stable point
is  5. The rest of the parameters are κ =  1.69, c =  1.46, e =  .95.
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Figure 4. Vaccine acceptance rate and disease incidence depend on the initial vaccine coverage and its
efficacy. Simulation of both vaccine coverage rate (a,c) and disease incidence (b,d) when initial vaccine
coverage is 50% (a) and 99% (c) at vaccine efficacy e =  0.95 and cost m =  0 which lie in the extension of
region III in subpanel (e) of the e—m plane of a bounded rational model. In (e) there are two bistability
regions where the equilibrium points  1 and  5 are stable in region III, and the equilibrium points  4 and  5
are stable in region II. Besides, equilibrium point  5 is stable in region I and in an extremely narrow stripe
between the two bistability regions II and III. Compare subpanel (e) to Fig. 2(a). The lines in (e) are stability
changing bifurcation lines. The rest of the parameters are κ =  1.69, c =  1.46, δV =  0.0725, δN =  0.02,
αV =  0.9715, αN =  0.9379, λV,o =  6.9507, λV,c =  9.4554, λN,o =  5.8909, λN,c =  1.9230, ηV =  0.9882, ηN =  0.9362.
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A6). In the latter two figures the closer the value of ηV and/or ηN to zero, the more the denial of the
adverse event, unless it is absolutely certain (has 100% likelihood to occur). That would make the value
of the average perceived risk of vaccine ( (0) > 0, see Appendix II for definition) very small and so
parents will accept the vaccine if there is a large initial proportion of vaccinators.
As noted above, under the bounded rationality model, in contrast to the rational decision model,
increasing vaccine efficacy may lead to oscillations instead of eradication (see the e–m plane in Fig. 2(c) versus 2(a) and the e–δV plane in Fig. 2(d)). Moreover, within a range of vaccine efficacy similar to that of
the DTaP, increasing vaccinator pressure can help in reaching full vaccine coverage, but it only reduces
disease prevalence by a factor μ (1 − x 6) e (which, here, is strictly less than μ = .0012) rather than
μ+γ
μ+γ
leading to full elimination. On the other hand, at a different set of parameter values in which the vaccinator group pressure instead exceeds the non-vaccinator group pressure, it is sometimes impossible to
achieve high level of vaccine acceptance if the size of vaccinator group was not initially large enough (see
for example Fig. 4(a,b) when the initial vaccination rate is 50%). However, for a larger initial vaccinator
group sizes, the disease may be eliminated for the same cognitive parameters (see for example Fig. 4(c,d)
when the initial vaccination rate is 99%).

Discussion

Research in cognitive psychology shows that humans make conflicting decisions when the same problem
is re-framed, not to mention the effect of other biases and fallacies on those decisions. Here, we introduce
a model of vaccine decision-making that includes bounded rationality, social norms, vaccine efficacy
and vaccine cost. In addition to social group pressure and the disease- specific parameters, the model
includes three cognitive parameters for each group of vaccinators and non-vaccinators. The model generalizes the model in33 by adding cognitive parameters and allowing vaccine efficacy to be less than perfect.
We find that richer dynamical behavior emerges from our model, in contrast to corresponding models that are closer to a pure “rational actor” model lacking bounded rationality and in which vaccine
efficacy is 100% (33). Allowing vaccine efficacy to be less than 100% causes the appearance of a new
equilibrium in which endemic disease with full vaccine acceptance becomes stable. It also transforms
the possible vaccine coverage level to a range from anywhere from zero to full coverage. Moreover,
generally speaking, introducing bounded rationality makes it more difficult to eliminate the infection
under a non-mandatory vaccination policy. This echoes many previous findings that introducing individual decision-making mechanisms could make it more difficult to eliminate an infection35,40,41,43,44,48.
However, injunctive social norms can correct for the deleterious effects of cognitive processes on vaccine
coverage. Combinations of cognitive parameters and group pressure can largely determine the vaccine
uptake. Non-vaccinator group pressure, however, has almost no effect on the vaccination dynamics at
some selected disease parameters. In addition, vaccine cost and efficacy have a significant effect on vaccine acceptance rates.
While full vaccine refusal is always a stable equilibrium in a rational decision model33,35, a bounded
rationality model can change the parameter regime where it is stable. Bounded rationality also gives rise
to stable limit cycles and partial vaccination levels. Parameter values close to those of a rational decision
model in addition to high group pressure can lead to full vaccine acceptance if the initial size of vaccinator group is large enough. Nonetheless, a very highly efficacious vaccine might be needed to eradicate the
disease. Vaccine cost and accessibility can lead to low rates of vaccine acceptance if vaccinator pressure
is not large enough.
The model introduced here has some challenges and limitations. First, the model has many cognitive
parameters, which hinders their estimation with the currently available data on vaccinating behaviour for
common paediatric infectious diseases. This also affects our understanding of the relative importance of
social versus cognitive components in parental vaccination decisions. Our simulations, however, suggest
that injunctive social norms can counteract the effect of (mis)perception of risks, high vaccination cost,
and low vaccine efficacy. The model did not also include age structure to differentiate between contact
rates between children and between adults57. Age structure could be important for certain research questions. Also, the model does not account for social network structure, and/or stochastic, small population
processes that may emerge close to the eradication threshold due to unanticipated interactions between
social structure, decision-making, and stochastic disease dynamics. Finally, previous experience with
vaccination or infection influences individual decision-making but we have not included such effects
here58. These and other effects could be best explored in future work using a individual-based network
simulation model.
The role of omission bias in vaccine acceptance and its representation in mathematical models merits
further investigation. Here, we tried to address omission bias by using different loss aversion parameters
for omission and commission. However, this is a simplification of omission bias. It would be also interesting to explore whether declining vaccination for the non-vaccinator group is considered an omission
or, from their point of view, it is a “commission” of the right thing. This kind of argument follows from
some early results finding that omission bias is not a driver of vaccine exemption59.
There has always been a need to understand how social and cognitive components affect parental
decisions towards vaccination. Our results show how combinations of both sets of parameters—along
with the vaccine efficacy, cost and the rates of vaccine acceptance at the beginning of the vaccination
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campaign—can determine the fate of vaccine acceptance. Empirical validation of such models developed for specific paediatric infectious diseases could help health authorities identify vaccine programs
that might be more prone to vaccine refusal in the future, and thus help authorities determine how to
prioritize risk messaging in light of knowledge of how individuals can sometimes mis-perceive risks.

References

1. Kahneman, D. Maps of bounded rationality: Psychology for behavioral economics. Am. Econ. Rev. 93, 1449–1475 (2003).
2. Tversky, A. & Kahneman, D. Advances in prospect theory: Cumulative representation of uncertainty. J. Risk Uncertainty 5,
297–323 (1992).
3. Gigerenzer, G. & Selten, R. [Rethinking rationality] Bounded rationality: The adaptive toolbox [Gigerenzer, G. & Selten, R. (eds.)]
[1–11] (MIT Press, Cambridge, MA, 1999).
4. Simon, H. A. [Bounded rationality] The new Palgrave: Utility and probability [Eatwell, J., Milgate, M. & Newman, P. (eds.)]
[15–18] (W. W. Norton, New York, 1987).
5. Simon, H. A. Theories of bounded rationality. Decision and Organization 1, 161–176 (1972).
6. Simon, H. A. Models of bounded rationality, Vol. 3: Empirically grounded economic reason (MIT press, Cambridge, MA, 1982).
7. Kahneman, D. & Tversky, A. Choices, values, and frames. Am. Psychol. 39, 341 (1984).
8. Whyte, G. Escalating commitment in individual and group decision making: A prospect theory approach. Organ. Behav. Hum.
Dec. 54, 430–455 (1993).
9. Camerer, C. F. [Prospect theory in the wild: Evidence from the field] Advances in Behavioral Economics [Camerer, C. F.,
Loewenstein, G. & Rabin, M. (eds.)] [148–161] (Princeton University press, Princeton, NJ, 2004).
10. Fiegenbaum, A. Prospect theory and the risk-return association: An empirical examination in 85 industries. J. Econ. Behav.
Organ. 14, 187–203 (1990).
11. Dhami, S. & Al-Nowaihi, A. Why do people pay taxes? Prospect theory versus expected utility theory. J. Econ. Behav. Organ. 64,
171–192 (2007).
12. Treadwell, J. R. & Lenert, L. A. Health values and prospect theory. Med. Decis. Making 19, 344–352 (1999).
13. Latimer, A. E. et al. Promoting participation in physical activity using framed messages: An application of prospect theory. Brit.
J. Health Psych. 13, 659–681 (2008).
14. Trepel, C., Fox, C. R. & Poldrack, R. A. Prospect theory on the brain? Toward a cognitive neuroscience of decision under risk.
Cognitive Brain Res. 23, 34–50 (2005).
15. Levy, J. S. Prospect theory, rational choice, and international relations. Int. Stud. Quart. 41, 87–112 (1997).
16. Farnham, B. Avoiding Losses, Taking Risks: Prospect Theory and International Conflict (University of Michigan Press, Ann Arbor,
MI, 1994).
17. Mercer, J. Prospect theory and political science. Annu. Rev. Polit. Sci. 8, 1–21 (2005).
18. Bloom, D. E., Canning, D. & Weston, M. The value of vaccination. World economics (Henley-on-Thames, England) 6, 15–39
(2005).
19. Bloom, D. E. The value of vaccination. Hot Topics in Infection and Immunity in Children VII, 1–8 (2011).
20. Andre, F. et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. B. World Health Organ. 86, 140–146
(2008).
21. Brown, K. F. et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: A systematic
review. Vaccine 28, 4235–4248 (2010).
22. Smith, P. J. et al. Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the health
belief model. Public Health Rep. 126 (Suppl 2) 135–146 (2011).
23. Bardenheier, B. et al. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and
tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children? Arch. Pediat. Adol. Med. 158, 569 (2004).
24. Hershey, J. C., Asch, D. A., Thumasathit, T., Meszaros, J. & Waters, V. V. The roles of altruism, free riding, and bandwagoning in
vaccination decisions. Organ. Behav. Hum. Dec. 59, 177–187 (1994).
25. Bauch, C. T. & Bhattacharyya, S. Evolutionary game theory and social learning can determine how vaccine scares unfold. PLoS
Comput. Biol. 8, e1002452 (2012).
26. Gangarosa, E. J. et al. Impact of anti-vaccine movements on pertussis control: The untold story. Lancet 351, 356–361 (1998).
27. Sugerman, D. E. et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: Role of the intentionally
undervaccinated. Pediatrics 125, 747–755 (2010).
28. Meszaros, J. R. et al. Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J.
Clin. Epidemiol. 49, 697–703 (1996).
29. Serpell, L. & Green, J. Parental decision-making in childhood vaccination. Vaccine 24, 4041–4046 (2006).
30. Bond, L. & Nolan, T. Making sense of perceptions of risk of diseases and vaccinations: A qualitative study combining models of
health beliefs, decision-making and risk perception. BMC Public Health 11, 943–956 (2011).
31. Poland, C. M. & Poland, G. A. Vaccine education spectrum disorder: The importance of incorporating psychological and
cognitive models into vaccine education. Vaccine 29, 6145–6148 (2011).
32. Wu, B., Fu, F. & Wang, L. Imperfect vaccine aggravates the long-standing dilemma of voluntary vaccination. PloS ONE 6, e20577
(2011).
33. Oraby, T., Thampi, V. & Bauch, C. T. The influence of social norms on the dynamics of vaccinating behaviour for paediatric
infectious diseases. Proc. R. Soc. B: Behaviour 281, 20133172 (2014).
34. Chapman, G. B. & Coups, E. J. Predictors of influenza vaccine acceptance among healthy adults. Prev. Med. 29, 249–262 (1999).
35. Bauch, C. T. Imitation dynamics predict vaccinating behaviour. Proc. R. Soc. B: Biological Sciences 272, 1669–1675 (2005).
36. Bauch, C. T., Bhattacharyya, S. & Ball, R. F. Rapid emergence of free-riding behavior in new pediatric immunization programs.
PloS ONE 5, e12594 (2010).
37. Reluga, T. C., Bauch, C. T. & Galvani, A. P. Evolving public perceptions and stability in vaccine uptake. Math. Biosci. 204,
185–198 (2006).
38. Reluga, T. C. & Galvani, A. P. A general approach for population games with application to vaccination. Math. Biosci. 230, 67–78
(2011).
39. Funk, S., Salathé, M. & Jansen, V. A. Modelling the influence of human behaviour on the spread of infectious diseases: A review.
J. R. Soc. Interface 7, 1247–1256 (2010).
40. Brito, D. L., Sheshinski, E. & Intriligator, M. D. Externalities and compulsary vaccinations. J. Public Econ. 45, 69–90 (1991).
41. d’Onofrio, A., Manfredi, P. & Poletti, P. The interplay of public intervention and private choices in determining the outcome of
vaccination programmes. PLoS ONE 7, e45653 (2012).
42. Fine, P. & Clarkson, J. A. Reflections on the efficacy of pertussis vaccines. Rev. Infect. Dis. 9, 866–883 (1987).
43. Tsutsui, Y., Benzion, U., Shahrabani, S. & Din, G. Y. A policy to promote influenza vaccination: a behavioral economic approach.
Health policy 97, 238–249 (2010).

Scientific Reports | 5:10724 | DOI: 10.1038/srep10724

11

www.nature.com/scientificreports/
44. Shahrabani, S., Gafni, A. & Ben-Zion, U. Low flu shot rates puzzle - some plausible behavioral explanations. Am. Econ. 52,
66–72 (2008).
45. Zhang, H., Zhang, J., Li, P., Small, M. & Wang, B. Risk estimation of infectious diseases determines the effectiveness of the control
strategy. Physica D: Nonlinear Phenomena 240, 943–948 (2011).
46. Zhang, H., Fu, F., Zhang, W. & Wang, B. Rational behavior is a ‘double-edged sword’ when considering voluntary vaccination.
Physica A: Statistical Mechanics and its Applications 391, 4807–4815 (2012).
47. Poletti, P., Ajelli, M. & Merler, S. Risk perception and effectiveness of uncoordinated behavioral responses in an emerging
epidemic. Math. Biosci. 238, 80–89 (2012).
48. Salathé, M. Bonhoeffer, S. The effect of opinion clustering on disease outbreaks J. R. Soc. Interface 5, 1505–1508 (2008).
49. Liò, P., Lucia, B., Nguyen, V. & Kitchovitch, S. [Risk perception, heuristics and epidemic spread] Modeling the Interplay Between
Human Behavior and the Spread of Infectious Diseases [Piero, M. & d’Onofrio, A. (eds.)] [139–152] (Springer, 2013).
50. Fennema, H. & Wakker, P. P. Original and cumulative prospect theory: A discussion of empirical differences. J. Behav. Decis.
Making 10, 53–64 (1997).
51. Lichtenstein, S., Slovic, P., Fischhoff, B., Layman, M. & Combs, B. Judged frequency of lethal events. J. Exp. Psychol.- Hum. L. 4,
551 (1978).
52. Wu, G. & Gonzalez, R. Curvature of the probability weighting function. Manage. Sci. 42, 1676–1690 (1996).
53. Ritov, I. & Baron, J. Reluctance to vaccinate: Omission bias and ambiguity. J. Behav. Decis. Making 3, 263–277 (1990).
54. Sturm, L. A., Mays, R. M. & Zimet, G. D. Parental beliefs and decision making about child and adolescent immunization: From
polio to sexually transmitted infections. J. Dev. Behav. Pediatr. 26, 441–452 (2005).
55. Centers for Disease Control and Prevention, Vaccines: Vac-Gen/Some Misconceptions - Risk from disease versus risk from
vaccines. (2011) Available at: http://www.cdc.gov/vaccines/vac-gen/6mishome.htm. (Accessed: 15th March 2014)
56. Centers for Disease Control and Prevention, Pertussis frequently asked questions. (2013) Available at: http://www.cdc.gov/
pertussis/about/faqs.html. (Accessed: 15th March 2014)
57. Schenzle, D. An age-structured model of pre-and post-vaccination measles transmission Math. Med. Biol. 1, 169–191 (1984).
58. Wells, C. R. & Bauch, C. T. The impact of personal experiences with infection and vaccination on behaviour-incidence dynamics
of seasonal influenza. Epidemics 4, 139–151 (2012).
59. Connolly, T. & Reb, J. Omission bias in vaccination decisions: Where’s the “omission”? Where’s the “bias”? Organ. Behav. Hum.
Dec. 91, 186-202 (2003).

Author Contributions

T.O. and C.B. wrote the manuscript text and produced the figures. T.O. and C.B. reviewed the manuscript.

Additional Information

Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Oraby, T. and Bauch, C. T. Bounded rationality alters the dynamics of
paediatric immunization acceptance. Sci. Rep. 5, 10724; doi: 10.1038/srep10724 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The
images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from the license holder to reproduce
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Scientific Reports | 5:10724 | DOI: 10.1038/srep10724

12

